COVID-19 State of Vaccine Confidence Insights Report 24 (February 1 - 21, 2022)   [open pdf - 827KB]

From the Document: "By rapidly reviewing and analyzing numerous sources and inputs [...], the COVID-19 [coronavirus disease 2019] State of Vaccine Confidence Insights Report emphasizes major themes influencing COVID-19 vaccine hesitancy and uptake. These are characterized by the level and type of threat to vaccine confidence, degree of spread, and directionality. In addition, by examining how consumers think and feel, social processes, and the practical issues around vaccination, the Insights Report seeks to identify emerging issues of misinformation, disinformation, and places where intervention efforts can improve vaccine confidence across the United States. The information in this report is only a snapshot, and certain populations may be underrepresented. Images and quotes are illustrative examples and are not meant to comprehensively cover all content related to the highlighted themes." Some major themes from this Insights Report include, "Consumers' interest in new COVID-19 vaccines from Ocugen-Bharat Biotech and Novavax, which are not yet FDA-authorized, but are WHO [World Health Organization] prequalified"; "Continued discussions on infection-induced immunity versus vaccine-induced immunity among the public"; "Increasing public perception that the pandemic is over; support for community mitigation efforts is waning"; "Myth emerged about a syndrome called Vaccine Acquired Immune Deficiency Syndrome (VAIDS)"; and "Some parents are disappointed in the delay of COVID-19 vaccines for children less than 5 years old while others are strongly opposed to pediatric vaccines."

Report Number:
COVID-19 State of Vaccine Confidence Insights Report No. 24
Public Domain
Retrieved From:
Centers for Disease Control and Prevention: https://www.cdc.gov/
Media Type:
Help with citations